Tobacco brands can fight counterfeit products by combining federal trademark registration, marketplace and retailer monitoring, evidence preservation, supply-chain controls, U.S. Customs and Border Protection recordation, FDA reporting, cease-and-desist enforcement, and federal litigation when necessary.

The first step is determining whether the suspect product is actually counterfeit.

Under federal trademark law, specialized counterfeiting remedies generally involve a spurious mark that is identical with, or substantially indistinguishable from, a qualifying trademark registered on the Principal Register and used for the relevant goods or services.

Federal tobacco law contains a separate tobacco-specific definition. FDA states that a “counterfeit tobacco product” includes a tobacco product, container, or labeling that, without authorization, bears the trademark, trade name, identifying mark, imprint, device, or a likeness of one associated with a tobacco product listed under the applicable FDA registration provision.

Those two frameworks can overlap, but they should not be treated as identical.

A fake cigar box reproducing a registered cigar trademark may present a Lanham Act counterfeiting case and a tobacco-regulatory problem. A seller offering an unauthorized electronic cigarette under its own unrelated branding may violate FDA requirements without necessarily committing trademark counterfeiting.

For tobacco companies, effective enforcement begins by identifying exactly what type of problem has occurred.

What Is a Counterfeit Tobacco Product?

In ordinary commercial language, companies often call any unauthorized imitation a counterfeit.

Federal law is more specific.

For the Lanham Act’s specialized civil counterfeiting remedies, the counterfeit mark generally must be a counterfeit of a mark registered on the Principal Register for the relevant goods or services and in use. The statutory definition focuses on marks that are essentially indistinguishable from the genuine trademark.

FDA’s tobacco framework separately defines a counterfeit tobacco product by reference to unauthorized use of another tobacco product’s trademark, trade name, or other identifying matter on the product, container, or labeling.

This tobacco-specific definition matters because counterfeit products are also part of FDA’s broader concern with illicit trade.

A tobacco brand facing fake products should therefore consider both intellectual property enforcement and tobacco-product regulation.

Is Every Fake-Looking Tobacco Product Legally Counterfeit?

No.

A product can imitate another brand without satisfying the specialized legal definition of trademark counterfeiting.

For example, a competitor might copy the general appearance of a cigar package while using a different name. That could raise trade dress, copyright, design patent, or unfair competition issues without necessarily constituting use of a counterfeit trademark.

Likewise, an electronic cigarette sold without required FDA marketing authorization may be unlawful from a tobacco-regulatory perspective even though it does not copy anyone else’s trademark.

FDA’s May 2026 enforcement guidance expressly distinguishes illicit and unauthorized tobacco products while identifying counterfeit products as one category of conduct receiving enforcement attention.

The enforcement strategy should therefore match the actual violation.

What Is the Difference Between Counterfeit Tobacco and Unauthorized Tobacco?

The concepts overlap in some cases, but they are not synonymous.

A counterfeit tobacco product improperly uses another company’s identifying branding.

An unauthorized tobacco product may violate FDA requirements concerning whether the product can legally be marketed in the United States even if its branding is entirely original.

FDA stated in May 2026 that its current enforcement priorities for unauthorized ENDS and nicotine pouch products include counterfeit and misdeclared products, while also emphasizing products that fail to comply with premarket authorization requirements.

A tobacco company should therefore avoid describing every unauthorized competitor product as counterfeit.

Accurate terminology makes enforcement more credible and helps identify the correct federal agency or legal remedy.

Why Is Federal Trademark Registration Important for Tobacco Anti-Counterfeiting?

Federal registration can substantially strengthen a brand’s enforcement position.

The Lanham Act’s ex parte civil seizure mechanism for counterfeit marks is specifically tied to qualifying marks registered on the Principal Register.

Registration also enables an important border-enforcement tool.

The USPTO explains that owners of qualifying Principal Register trademarks registered for goods can separately record those registrations with U.S. Customs and Border Protection. CBP recordation can help customs officials detain and seize imported merchandise bearing counterfeit or infringing versions of recorded trademarks.

For cigar, tobacco, vape, nicotine pouch, and related product brands whose counterfeits are manufactured abroad, that can be particularly valuable.

Federal registration is therefore not simply a marketing asset. It can become part of the company’s anti-counterfeiting infrastructure.

Which Tobacco Trademarks Should Be Registered?

The company’s most commercially important source identifiers generally deserve priority.

That often begins with the primary house mark.

Important cigar-line names, vape-device brands, e-liquid brands, nicotine pouch brands, and other independently recognized product marks may also merit separate protection.

Major logos can be protected separately when counterfeiters are likely to reproduce visual branding even when they avoid writing the complete brand name in product titles.

Distinctive packaging may also potentially receive trade dress protection if it satisfies the applicable requirements.

The goal is to make sure counterfeiters cannot easily move from copying one protected element to another unprotected but equally recognizable part of the brand.

Does Registering the Company Name Protect Every Tobacco Product Name?

No.

A registration for the parent or house brand does not automatically register every cigar line, vape device, e-liquid, nicotine pouch, or product-family name used by the company.

If counterfeiters are targeting a specific product name that consumers recognize independently, the company should determine whether that name itself deserves federal protection.

A layered trademark portfolio can make enforcement more flexible.

For example, one fake product might copy the house mark while another reproduces only a famous product-line name or logo.

Each independently registered asset can provide an additional enforcement basis when appropriate.

Should Tobacco Brands Monitor the Marketplace for Counterfeits?

Yes.

Counterfeit enforcement is usually easier when suspect products are identified before they become widely distributed.

Monitoring can include tobacconists, vape retailers, wholesalers, ecommerce sites, social media, independent websites, online marketplaces, distributor catalogs, trade shows, and other channels through which customers discover tobacco products.

Monitoring should not depend solely on exact brand-name searches.

Counterfeit sellers may misspell trademarks, omit them from listing titles, hide them within photographs, abbreviate product names, or describe the products generically while displaying copied packaging.

The company should therefore monitor both words and visual presentation.

Should Cigar Brands Monitor Physical Retailers?

Yes.

Counterfeit cigars can move through traditional distribution channels as well as online marketplaces.

Brands may receive useful information from authorized tobacconists, distributors, sales representatives, lounges, and consumers who notice products with unusual packaging, pricing, construction, bands, or sourcing.

An authorized retail and distribution network can therefore serve as an early-warning system.

The company should provide genuine partners with a clear process for reporting suspicious goods rather than expecting individual retailers to investigate counterfeiting independently.

Should Vape Brands Monitor Online Sellers?

Yes.

Online monitoring is especially important for ENDS and related products because sellers can appear and disappear quickly.

FDA continues to monitor online tobacco retailers and manufacturers as part of its enforcement activity. Its current tobacco retailer warning-letter database includes numerous online businesses, including 2026 actions involving unauthorized tobacco products.

Trademark owners should separately monitor unauthorized use of their brands.

A seller may operate through its own website, social media, an online marketplace, or several channels simultaneously.

Preserving connections among those accounts can help identify a larger seller network.

What Evidence Should a Tobacco Brand Preserve Before Sending a Takedown?

Evidence should generally be collected before the seller receives notice.

Once contacted, a counterfeiter may remove the listing, alter photographs, change business names, delete social accounts, or move inventory.

Useful evidence can include product-page screenshots, complete URLs, seller names, account identifiers, product photographs, prices, quantities where visible, customer reviews, advertisements, shipping representations, and dates.

If commercially and legally appropriate, the brand may also obtain a sample of the suspected counterfeit through a controlled purchase.

The company should preserve the product, packaging, shipping container, receipt, invoice, return address, tracking information, and other materials associated with the purchase.

A physical sample can reveal details that online photographs do not.

Should the Brand Compare Suspected Counterfeits With Authentic Products?

Yes.

An authentication analysis can strengthen an enforcement file.

The company can document differences in printing, cigar bands, packaging materials, tax or regulatory markings, serial or lot information, manufacturing quality, product configuration, seals, labels, ingredients, or other characteristics.

The analysis should rely on genuine reference samples with known provenance.

For tobacco products, this may be particularly significant where suspect goods raise quality or safety concerns.

FDA allows anyone to report problems involving tobacco products, including defective or contaminated products and tobacco products associated with health or safety concerns.

Can Tobacco Brands Use Lot Codes or Serialization Against Counterfeits?

Yes, as part of a broader commercial authentication strategy.

Brands can use internal lot identifiers, serialization, packaging controls, secure labels, QR-based verification systems, or other mechanisms to make genuine products easier to distinguish from fakes.

These measures do not create trademark rights by themselves.

They can, however, support investigations, retailer education, supply-chain tracing, and evidence showing that a suspicious product did not pass through authorized production or distribution.

Federal tobacco law also expressly recognizes the importance of tracking and tracing illicit trade. Section 920 authorizes measures concerning records and potentially codes or other devices used to track tobacco products through distribution.

A company’s private authentication program should still be designed around its actual products and regulatory obligations.

Why Is Supply-Chain Control Important?

Counterfeiting is not always visible first through an online seller.

Problems can originate through unauthorized manufacturing, diverted packaging, rogue distributors, compromised suppliers, or products entering distribution outside the approved channel.

Tobacco companies should know which manufacturers, distributors, importers, wholesalers, and retailers are authorized to handle the brand.

Contracts can restrict unauthorized production and use of trademarks, require control over unused labels and packaging, impose confidentiality obligations, and address termination inventory.

The company should also know what happens to obsolete cigar bands, packaging plates, molds, labels, and branded components when a manufacturing relationship ends.

Controlling those materials can reduce opportunities for unauthorized production.

Can a Private-Label Manufacturer Produce Counterfeit Versions of Its Customer’s Tobacco Brand?

Potentially, if it produces unauthorized branded goods outside the scope of permission.

However, the legal analysis can depend on when and how the manufacturer was authorized to use the mark.

The Lanham Act’s specialized counterfeit-mark definition contains an exclusion relating to goods whose manufacturer or producer was authorized, at the relevant time, to use the mark for that type of goods.

That means disputes involving factory overruns, former manufacturers, or authorized licensees can require more nuanced analysis than a straightforward fake product produced by an unrelated counterfeiter.

Manufacturing agreements should therefore define the scope and termination of trademark authorization clearly.

Can Marketplace Takedowns Stop Counterfeit Tobacco Products?

They can be an efficient first-line tool when counterfeit goods are sold through a platform that accepts intellectual property complaints.

The trademark owner should identify the exact registered mark, explain how it is being used without authorization, and preserve the listing before submitting the report.

The company should avoid claiming that a product is counterfeit merely because the seller is unauthorized.

A seller offering genuine goods without permission can present a different legal issue.

Likewise, a lookalike package using a different trademark may be better addressed through trade dress, copyright, or another right.

Accurate reporting reduces the risk of disputes over unsupported takedowns.

Is an Unauthorized Resale of Genuine Cigars a Counterfeit?

Not automatically.

A product does not become counterfeit simply because it was sold outside an authorized distribution network.

If the product is genuine, ordinary trademark counterfeiting principles may not apply in the same manner.

Different legal issues can arise when goods are materially different, altered, repackaged, damaged, imported through unauthorized channels, or marketed in ways that create confusion about affiliation or warranty coverage.

A brand should therefore authenticate the goods before labeling an unauthorized reseller a counterfeiter.

This distinction is particularly important for products that legitimately move through distributors and secondary markets.

Can a Brand Report Suspected Counterfeit Tobacco Products to FDA?

Potentially.

FDA maintains a process for reporting potential violations of the Tobacco Control Act and related tobacco regulations.

FDA states that reports can include the manufacture or sale of unauthorized tobacco products. Reports may be submitted through its tobacco-violation reporting system, after which FDA can evaluate the information and potentially conduct inspections, compliance checks, surveillance, or other investigation.

A trademark owner should understand what FDA enforcement addresses.

FDA is not simply a substitute for a private trademark infringement lawsuit. Its focus is compliance with federal tobacco law.

If the counterfeit conduct also involves unauthorized or otherwise illegal tobacco products, however, regulatory reporting may complement trademark enforcement.

Does FDA Specifically Regulate Counterfeit Tobacco Products?

Yes.

The Tobacco Control Act expressly addresses counterfeit tobacco products.

FDA’s statutory materials identify forging, counterfeiting, simulating, or improperly using another party’s trademark, trade name, identifying mark, stamp, tag, label, or similar device to create a counterfeit tobacco product as prohibited conduct. The statute also addresses selling or holding counterfeit tobacco products for sale.

FDA also has authority to investigate potential illicit trade, smuggling, and counterfeiting through record inspections under the tobacco framework.

This gives tobacco counterfeiting a regulatory dimension beyond the ordinary consumer-product trademark dispute.

Is FDA Actively Enforcing Against Illicit Tobacco Products in 2026?

Yes.

In May 2026, FDA issued updated enforcement-priority guidance concerning unauthorized ENDS and nicotine pouch products and specifically identified counterfeit products among the deceptive or serious forms of illicit conduct receiving attention. FDA also stated that it works with the Department of Justice, CBP, and other federal agencies to prevent illegal products from entering the country.

FDA has also continued issuing warning letters and other enforcement actions against manufacturers, distributors, importers, and retailers dealing in unauthorized tobacco products.

Trademark owners should nevertheless distinguish public regulatory enforcement from their own responsibility to protect private trademark rights.

Can Tobacco Brands Record Their Trademarks With U.S. Customs?

Yes, when the registration qualifies.

The USPTO states that the trademark must be registered on the Principal Register and registered for use on goods before it can be recorded with CBP. The owner then separately applies for CBP recordation and maintains that recordation through renewal.

CBP recordation can help officers detain and seize imported goods that violate the recorded trademark.

This can be particularly useful for cigar, vape, tobacco, and nicotine brands whose counterfeit products are produced outside the United States.

Recordation does not replace marketplace monitoring or litigation.

It adds an enforcement layer at the border.

What Information Should a Tobacco Brand Give CBP?

The more effectively CBP can distinguish genuine from suspicious products, the more useful recordation can become.

The USPTO notes that recorded trademark owners often provide information concerning authorized manufacturers and importers as well as potentially unauthorized shipments.

Brands can maintain current information concerning genuine packaging, authorized factories, known importers, product identifiers, manufacturing countries, shipping patterns, and visible authenticity features.

CBP also encourages recordation holders to remain engaged and keep recordation information current. Its 2026 guidance notes that rights owners can provide training to CBP personnel and report suspect shipments or importers through available enforcement channels.

Border enforcement works best when the trademark owner provides more than a registration number.

What Happens When CBP Finds Counterfeit Goods?

Federal customs law provides for seizure and forfeiture of qualifying imported merchandise bearing counterfeit marks.

19 U.S.C. § 1526 provides that imported merchandise bearing a counterfeit mark can be seized and, absent the trademark owner’s consent, forfeited under customs law.

CBP regulations likewise provide that, after determining imported merchandise bears a counterfeit mark, CBP will seize the merchandise and can provide specified importation information to the owner of the recorded mark.

This makes CBP recordation particularly valuable when a brand’s counterfeit problem originates abroad.

Stopping goods before they enter wholesale and retail channels may be substantially more efficient than pursuing dozens of downstream sellers afterward.

Can a Tobacco Brand Report a Suspect Shipment to CBP?

Yes.

Current CBP guidance states that rights owners can report suspect shipments or parties importing infringing merchandise through CBP’s e-Allegations system and can also engage the National Intellectual Property Rights Coordination Center for additional enforcement opportunities.

Specific shipment information, importer information, product descriptions, supporting photographs, and evidence of the trademark rights can help make the report more useful.

A brand should still distinguish an intellectual property violation from a regulatory problem involving an unauthorized but independently branded tobacco product.

Should a Tobacco Brand Send a Cease-and-Desist Letter?

Sometimes.

A cease-and-desist letter can be effective against an identifiable retailer, distributor, manufacturer, or online seller.

The letter can identify the trademark rights, explain the challenged conduct, demand cessation of unauthorized trademark use, request removal of products, seek preservation of evidence, and address remaining inventory.

However, advance notice is not always strategically desirable.

A sophisticated counterfeiter may use notice to destroy records, move inventory, close accounts, transfer assets, or conceal the operation.

The enforcement sequence should therefore reflect the scale and sophistication of the suspected counterfeiting activity.

Can a Tobacco Brand Sue a Counterfeiter in Federal Court?

Yes, when the applicable requirements are satisfied.

The Lanham Act provides civil remedies for infringement of registered trademarks, including specialized remedies for qualifying counterfeit marks.

In serious cases, courts can issue injunctions prohibiting continued infringement.

Federal law also provides an extraordinary ex parte seizure mechanism that can permit seizure of counterfeit goods, counterfeit marks, manufacturing means, and records without advance notice when the demanding statutory requirements are established.

That remedy is intentionally difficult to obtain.

It should not be confused with submitting an ordinary marketplace takedown request.

Can a Court Seize Counterfeit Cigars or Vape Products Without Warning the Seller?

Potentially.

Section 1116(d) allows federal courts to grant ex parte seizure orders in qualifying counterfeit-mark cases.

The applicant must satisfy a series of statutory requirements intended to justify proceeding without notice, including circumstances indicating that ordinary relief would be inadequate and that evidence or goods may become unavailable if advance notice is given.

For large-scale counterfeiting operations, this can provide a powerful enforcement mechanism.

For an isolated small seller, less drastic enforcement may be more proportionate.

What Statutory Damages Are Available for Trademark Counterfeiting?

Federal law allows qualifying trademark owners to elect statutory damages instead of attempting to prove actual damages and the counterfeiter’s profits.

Under 15 U.S.C. § 1117(c), statutory damages currently range from $1,000 to $200,000 per counterfeit mark per type of goods or services.

When the court finds the use of the counterfeit mark was willful, damages can reach $2 million per counterfeit mark per type of goods or services.

These figures are statutory ranges, not automatic awards.

The trademark owner still must establish a qualifying counterfeiting case, and the court determines the appropriate amount.

Can a Tobacco Brand Recover Triple Damages?

Potentially.

15 U.S.C. § 1117(b) provides enhanced remedies in specified cases involving intentional use of counterfeit marks.

When the statutory requirements are satisfied and no extenuating circumstances are found, the court generally enters judgment for three times the greater of profits or damages, together with reasonable attorneys’ fees.

These enhanced remedies are another reason to distinguish true statutory counterfeiting from ordinary infringement.

A competitor using a somewhat similar cigar name can create a serious trademark case without necessarily triggering counterfeit-mark remedies.

Can Copyright Help Tobacco Brands Fight Counterfeit Packaging?

Potentially.

A counterfeit cigar box, vape package, or tobacco label may reproduce more than the trademark.

It may also copy original illustrations, product photography, graphic artwork, or other copyrighted material.

Those elements can create a separate copyright enforcement basis when the company owns the relevant rights.

This can be useful when counterfeiters alter the word mark slightly but continue reproducing proprietary photographs or packaging artwork.

Trademark and copyright should therefore be evaluated independently.

One counterfeit product may violate both.

Can Trade Dress Protect Tobacco Packaging From Counterfeiters?

Potentially.

A company may have protectable rights in distinctive, nonfunctional packaging independently from its word trademarks.

For a cigar company, that might involve a recognizable cigar-box or band presentation.

For a vape or nicotine product, it could involve a distinctive package configuration or graphic system.

Trade dress protection is subject to its own distinctiveness and functionality requirements, so the company should not assume that ordinary packaging is proprietary.

Where strong packaging trade dress exists, however, it can provide another enforcement tool against sellers that imitate the presentation while modifying the exact trademark.

Can Counterfeit Products Create Safety and Reputation Problems?

Yes.

Counterfeits can damage more than sales.

Consumers purchasing a fake product may believe they are using an authentic product manufactured under the brand owner’s standards.

If the product is defective, contaminated, improperly manufactured, or materially different from the genuine product, the customer may still associate the resulting experience with the genuine brand.

FDA specifically allows tobacco-product problem reports concerning damaged, defective, or contaminated products and products associated with health or safety concerns.

FDA also stated in its 2026 enforcement guidance that illicit tobacco products can undermine the regulatory framework and expose consumers to products that have not undergone required review.

For regulated products, counterfeiting can therefore create both intellectual property and public-health concerns.

What Should a Brand Do if a Customer Reports a Suspected Counterfeit?

The company should preserve the report and attempt to document the product’s source.

Useful information can include photographs of the product and packaging, where it was purchased, purchase date, receipt, seller name, online listing, lot information, shipping materials, and any authenticity identifiers.

If the consumer reports a health or safety problem, the company should separately follow appropriate regulatory and product-safety procedures.

FDA’s tobacco-product reporting guidance specifically asks for information including manufacturer and brand name, device or e-liquid model and serial number where applicable, purchase location, product modifications, and details of any adverse experience.

Customer reports can therefore provide valuable intelligence if they are documented systematically.

Should Brands Maintain an Authorized Seller List?

It can be useful.

An authorized seller or distributor structure helps a company understand where authentic goods should enter the market.

It can also help customers, retailers, and investigators determine whether a suspicious seller sits outside the ordinary distribution network.

However, being unauthorized does not automatically make the seller a counterfeiter.

The company still needs to determine whether the goods themselves are genuine.

Authorized seller information should therefore serve as an investigative clue rather than automatic proof of trademark counterfeiting.

What Should a Brand Do if Counterfeit Sellers Keep Returning?

A listing-by-listing strategy may be inadequate.

The company should look for connections among sellers.

Those can include common contact information, domain registrations, shipping addresses, payment details, packaging, product photographs, website templates, descriptions, import sources, or fulfillment patterns.

The goal is to determine whether apparently separate accounts are part of the same operation.

Evidence connecting sellers can affect whether marketplace complaints, direct demands, federal litigation, border enforcement, or agency reporting provides the most efficient response.

The enforcement program should target the source of the counterfeit network whenever possible rather than repeatedly treating each listing as an isolated incident.

Should Tobacco Brands Publicly Warn Consumers About Counterfeits?

Sometimes, but communications should be carefully drafted.

A brand may have legitimate reasons to educate customers about how to identify authentic products, where authorized products can be purchased, or whether particular counterfeit goods are circulating.

The company should avoid unnecessary speculation or unsupported accusations against particular businesses.

It should also avoid making statements that inaccurately imply FDA approval or endorsement of its own products.

Federal tobacco law expressly prohibits misleading consumers into believing that a tobacco product is approved, deemed safe, or endorsed by FDA merely because of the product’s regulatory status.

Consumer education should therefore focus on authenticity without making unsupported regulatory claims.

Should Tobacco Brands Work With Regulators and Law Enforcement?

Serious cases may justify coordinated enforcement.

FDA stated in 2026 that it works with agencies including DOJ and CBP to address illicit tobacco products and prevent unlawful products from entering U.S. commerce.

Trademark owners can separately use CBP recordation, provide information concerning suspicious imports, submit tobacco violations to FDA, and pursue their private civil remedies.

Different agencies have different mandates.

A brand should not assume that reporting the matter to FDA automatically protects the company’s private trademark rights or that filing a trademark lawsuit resolves FDA regulatory issues.

The strongest strategy may use several tools for different purposes.

When Should Counterfeit Enforcement Be Escalated?

Escalation should reflect the scale and risk of the problem.

An isolated low-volume online listing may be addressed efficiently through evidence preservation and a platform complaint.

Repeated sales through multiple accounts may justify deeper seller investigation.

Large shipments entering from abroad may make CBP involvement particularly important.

An identifiable manufacturer or distributor producing significant counterfeit inventory may justify direct legal demands or litigation.

Products presenting potential health, safety, or regulatory concerns may also justify FDA reporting.

The company should focus resources where the infringement threatens brand goodwill, consumer trust, legitimate distribution, or product integrity most seriously.

What Are the Biggest Anti-Counterfeiting Mistakes Tobacco Brands Make?

One mistake is waiting until counterfeits are widespread before registering important trademarks.

Another is calling every unauthorized seller a counterfeiter without authenticating the goods.

Brands may also submit platform complaints before preserving evidence, making it difficult to investigate the seller once the listing disappears.

Other companies obtain federal trademark registrations but never record qualifying marks with CBP despite substantial international counterfeit risk.

Some fail to control manufacturing files, unused labels, packaging, and authorized distribution channels.

Another mistake is treating trademark infringement and FDA regulatory violations as the same issue.

A tobacco brand should understand which problem it is trying to solve before selecting an enforcement mechanism.

How Can Tobacco Brands Build an Anti-Counterfeiting Program Before Problems Begin?

The strongest program begins before counterfeit goods are discovered.

The company should register its most important house marks, product names, and logos for the tobacco goods actually sold under them.

Where international counterfeiting is a realistic concern, qualifying Principal Register registrations can be recorded with CBP.

The company should maintain authentic reference samples, current packaging specifications, authorized manufacturer and importer information, and product-identification systems that help distinguish genuine goods.

Manufacturing and distribution agreements should restrict unauthorized trademark use and address leftover branded inventory.

Retailers and distributors should have a clear process for reporting suspicious products.

Online and physical monitoring should begin before a major counterfeit network develops.

Finally, the company should establish an internal escalation process identifying when a matter should go to a marketplace, trademark counsel, CBP, FDA, or federal court.

How Should a Tobacco Brand Respond After Finding Counterfeit Products?

First, preserve the evidence.

Document the seller, product, packaging, website, transaction, and suspected connections with other accounts before giving notice.

Second, authenticate the goods and identify precisely which rights have been violated.

Determine whether the product involves true counterfeit trademark use, ordinary trademark infringement, trade dress copying, copyright infringement, unauthorized resale, or an FDA regulatory problem.

Third, verify the trademark portfolio.

Principal Register registrations covering the relevant goods can materially strengthen civil counterfeiting remedies and may qualify for CBP recordation.

Fourth, select the appropriate enforcement channel.

An online listing might warrant a marketplace complaint. An imported shipment may justify CBP action. A suspected Tobacco Control Act violation can be reported to FDA. A sophisticated manufacturer or distributor may require a cease-and-desist demand or federal litigation.

Finally, use the incident to improve the company’s broader anti-counterfeiting program.

Counterfeit enforcement should not become an endless sequence of isolated takedowns.

For tobacco brands, the stronger approach combines trademark rights, supply-chain intelligence, retailer relationships, border protection, regulatory reporting, and strategic civil enforcement so counterfeit goods can be identified and stopped at several points before they reach consumers.

Cohn Legal, PLLC advises cigar, tobacco, vape, nicotine, and other consumer-product businesses on trademark registration, counterfeiting, CBP recordation, online enforcement, packaging and trade dress, licensing, TTAB proceedings, and federal trademark disputes.

Primary Sources and Authorities

15 U.S.C. § 1116(d) contains the Lanham Act’s specialized civil seizure provisions for qualifying counterfeit-mark cases. It defines the relevant counterfeit mark by reference to qualifying marks registered on the Principal Register and permits ex parte seizure under specified statutory circumstances.

15 U.S.C. § 1117(b) and (c) provide enhanced monetary remedies for qualifying trademark counterfeiting. Section 1117(c) currently permits statutory damages from $1,000 to $200,000 per counterfeit mark per type of goods or services, with a maximum of $2 million per counterfeit mark per type of goods or services for willful use.

FDA’s implementation of Section 900 of the Federal Food, Drug, and Cosmetic Act defines a counterfeit tobacco product as a tobacco product, container, or labeling that without authorization bears another qualifying tobacco product’s trademark, trade name, identifying mark, imprint, device, or likeness.

Federal tobacco law separately identifies counterfeiting, unauthorized use of identifying labels or marks, and the sale or possession for sale of counterfeit tobacco products as prohibited conduct.

Section 920 of the FD&C Act, as reflected in FDA’s Tobacco Control Act materials, provides record-inspection and tracking-related authority directed at potential illicit trade, smuggling, and counterfeiting of tobacco products.

USPTO guidance concerning U.S. Customs and Border Protection recordation provides that an owner of a qualifying Principal Register trademark registered for goods can separately record that trademark with CBP to assist border officials in detaining and seizing counterfeit or infringing imports.

19 U.S.C. § 1526(e) provides for seizure and forfeiture of qualifying imported merchandise bearing counterfeit marks. CBP regulations additionally govern seizure procedures and disclosure of importation information to owners of recorded marks.

FDA’s May 8, 2026 enforcement-priority guidance confirms that counterfeit products remain part of the agency’s current strategy concerning illicit ENDS and nicotine pouch products and describes ongoing coordination with DOJ, CBP, and other federal agencies.

FDA also maintains a formal process through which suspected Tobacco Control Act violations can be reported for agency evaluation and possible inspection, surveillance, or other follow-up.

Author: Abraham Cohn, U.S. trademark attorney and founder of Cohn Legal, PLLC. Cohn Legal advises cigar, tobacco, vape, nicotine, consumer-product, and regulated-product companies on trademark registration, online and border enforcement, counterfeit goods, CBP recordation, trade dress, licensing, TTAB proceedings, and federal trademark disputes.